February 18: Netanyahu Medical Report Refutes Prostate Cancer Rumors
On 18 February, Israel released a Netanyahu medical report confirming no prostate cancer and treatment for a post-surgery UTI with antibiotics. This clarity cools speculation around leadership stability. For Singapore investors, the update can ease short-term geopolitical risk, steady haven flows, and lower headline volatility. We break down what changed, why it matters to SG portfolios, and what to watch next. Our focus is clear guidance and practical steps, using only verified details on Netanyahu health and market context.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →